Selected article for: "disease onset day and severe patient"

Author: Christine Dahlke; Jasmin Heidepriem; Robin Kobbe; Rene Santer; Till Koch; Anahita Fathi; My L. Ly; Stefan Schmiedel; Peter H. Seeberger; Marylyn M. Addo; Felix F. Loeffler
Title: Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series
  • Document date: 2020_4_17
  • ID: icl1t9d6_32
    Snippet: Both patients showed a similar viral load of SARS-CoV-2 following infection (Pfefferle et al., submitted) . While the proportion of plasmablasts was increased early after symptom onset and then decreased in patient #2 (very mild disease course), the relative plasmablast frequency further increased up to d16 in patient #1 (more severe disease course). After the disease had subsided (d32), the percentage of plasmablasts decreased. Similar observati.....
    Document: Both patients showed a similar viral load of SARS-CoV-2 following infection (Pfefferle et al., submitted) . While the proportion of plasmablasts was increased early after symptom onset and then decreased in patient #2 (very mild disease course), the relative plasmablast frequency further increased up to d16 in patient #1 (more severe disease course). After the disease had subsided (d32), the percentage of plasmablasts decreased. Similar observations have been made in a study of a COVID-19 positive female patient, showing a peak of CD19+CD27+CD38+ cells in the blood at day 8 post disease onset, before symptoms were resolved. 8

    Search related documents:
    Co phrase search for related documents
    • blood cell peak and female patient: 1
    • cell peak and disease course: 1
    • cell peak and early increase: 1
    • cell peak and female patient: 1
    • cell peak and infection following: 1, 2, 3
    • cell peak and mild disease course: 1
    • disease course and early increase: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • disease course and female patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • disease course and infection following: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease course and mild disease course: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease course and patient decrease: 1, 2
    • disease course and SARS viral load: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • disease course and severe disease course: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • early increase and infection following: 1
    • early increase and patient decrease: 1, 2
    • early increase and SARS viral load: 1
    • early increase and severe disease course: 1, 2, 3
    • female patient and patient decrease: 1
    • female patient and positive female patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19